Lv L, Miao Q, Zhan S, Chen P, Liu W, Lv J
J Immunother Cancer. 2024; 12(12).
PMID: 39694700
PMC: 11660338.
DOI: 10.1136/jitc-2024-009444.
Guo L, Zhao Q, Wang M
J Funct Biomater. 2024; 15(10).
PMID: 39452576
PMC: 11509066.
DOI: 10.3390/jfb15100277.
Chaouat A, Kalechman Y, Hay O, Manoim J, Lantner T, Niderberg E
Int J Biol Sci. 2024; 20(11):4407-4423.
PMID: 39247817
PMC: 11380454.
DOI: 10.7150/ijbs.95350.
Zhao K, Wu C, Li X, Niu M, Wu D, Cui X
Front Immunol. 2024; 15:1401528.
PMID: 38881902
PMC: 11176514.
DOI: 10.3389/fimmu.2024.1401528.
Wang K, Wang L, Wang Y, Xiao L, Wei J, Hu Y
Mol Ther. 2024; 32(9):2835-2855.
PMID: 38273655
PMC: 11403237.
DOI: 10.1016/j.ymthe.2024.01.027.
M2 macrophage-derived exosomes suppress tumor intrinsic immunogenicity to confer immunotherapy resistance.
Zheng N, Wang T, Luo Q, Liu Y, Yang J, Zhou Y
Oncoimmunology. 2023; 12(1):2210959.
PMID: 37197441
PMC: 10184604.
DOI: 10.1080/2162402X.2023.2210959.
Epigenetic reprogramming of Runx3 reinforces CD8 + T-cell function and improves the clinical response to immunotherapy.
Liu Z, Li X, Gao Y, Liu J, Feng Y, Liu Y
Mol Cancer. 2023; 22(1):84.
PMID: 37189103
PMC: 10186650.
DOI: 10.1186/s12943-023-01768-0.
Study protocol of KeyPemls-004: A phase 2 study of pembrolizumab in combination with plinabulin and docetaxel in previously treated patients with metastatic non-small cell lung cancer and progressive disease (PD) after immunotherapy (PD-1/PD-L1....
Liu J, Chen M, Gao X, Liu X, Zhao J, Pan R
Thorac Cancer. 2023; 14(8):773-778.
PMID: 36725772
PMC: 10008678.
DOI: 10.1111/1759-7714.14806.
Radiomic Analysis Based on Magnetic Resonance Imaging for Predicting PD-L2 Expression in Hepatocellular Carcinoma.
Tao Y, Shi Y, Gong X, Li L, Li Z, Yang L
Cancers (Basel). 2023; 15(2).
PMID: 36672315
PMC: 9856314.
DOI: 10.3390/cancers15020365.
Recombinant single-cycle influenza virus with exchangeable pseudotypes allows repeated immunization to augment anti-tumour immunity with immune checkpoint inhibitors.
Kandasamy M, Gileadi U, Rijal P, Tan T, Lee L, Chen J
Elife. 2023; 12.
PMID: 36626205
PMC: 9831609.
DOI: 10.7554/eLife.76414.
Current options and future perspectives in the treatment of patients with relapsed/refractory diffuse large B-cell lymphoma.
Frontzek F, Karsten I, Schmitz N, Lenz G
Ther Adv Hematol. 2022; 13:20406207221103321.
PMID: 35785244
PMC: 9243592.
DOI: 10.1177/20406207221103321.
Nivolumab-induced lichenoid granulomatous stomatitis in a patient with advanced melanoma: A case report.
Gouveris P, Georgakopoulou E, Grigoraki A, Zouki D, Kardara V, Ioannou S
Mol Clin Oncol. 2022; 16(4):79.
PMID: 35251630
PMC: 8892467.
DOI: 10.3892/mco.2022.2512.
PD-1/PD-L1 Checkpoint Inhibitors in Tumor Immunotherapy.
Liu J, Chen Z, Li Y, Zhao W, Wu J, Zhang Z
Front Pharmacol. 2021; 12:731798.
PMID: 34539412
PMC: 8440961.
DOI: 10.3389/fphar.2021.731798.
Natural Killer Cells and Regulatory T Cells Cross Talk in Hepatocellular Carcinoma: Exploring Therapeutic Options for the Next Decade.
Bozward A, Warricker F, Oo Y, Khakoo S
Front Immunol. 2021; 12:643310.
PMID: 33995362
PMC: 8120158.
DOI: 10.3389/fimmu.2021.643310.
Nanoscale coordination polymers induce immunogenic cell death by amplifying radiation therapy mediated oxidative stress.
Huang Z, Wang Y, Yao D, Wu J, Hu Y, Yuan A
Nat Commun. 2021; 12(1):145.
PMID: 33420008
PMC: 7794559.
DOI: 10.1038/s41467-020-20243-8.
Down-regulation of EOMES drives T-cell exhaustion via abolishing EOMES-mediated repression of inhibitory receptors of T cells in liver cancer.
He H, Yi Y, Cai X, Wang J, Ni X, Fu Y
J Cell Mol Med. 2020; 25(1):161-169.
PMID: 33325636
PMC: 7810931.
DOI: 10.1111/jcmm.15898.
Nanoscale metal-organic frameworks for x-ray activated in situ cancer vaccination.
Ni K, Lan G, Guo N, Culbert A, Luo T, Wu T
Sci Adv. 2020; 6(40).
PMID: 33008911
PMC: 7852401.
DOI: 10.1126/sciadv.abb5223.
The MDM2 ligand Nutlin-3 differentially alters expression of the immune blockade receptors PD-L1 and CD276.
Li R, Zatloukalova P, Muller P, Gil-Mir M, Kote S, Wilkinson S
Cell Mol Biol Lett. 2020; 25:41.
PMID: 32874188
PMC: 7457494.
DOI: 10.1186/s11658-020-00233-w.
Dual pH-sensitive nanodrug blocks PD-1 immune checkpoint and uses T cells to deliver NF-κB inhibitor for antitumor immunotherapy.
Xiao Z, Su Z, Han S, Huang J, Lin L, Shuai X
Sci Adv. 2020; 6(6):eaay7785.
PMID: 32076650
PMC: 7002126.
DOI: 10.1126/sciadv.aay7785.
A Nanoscale Metal-Organic Framework to Mediate Photodynamic Therapy and Deliver CpG Oligodeoxynucleotides to Enhance Antigen Presentation and Cancer Immunotherapy.
Ni K, Luo T, Lan G, Culbert A, Song Y, Wu T
Angew Chem Int Ed Engl. 2019; 59(3):1108-1112.
PMID: 31642163
PMC: 8253508.
DOI: 10.1002/anie.201911429.
